What the agency says to do
FDA’s record gives no instruction for consumers.
Status: Ongoing. What the FDA’s recall statuses mean (opens in a new tab)
Note from Recalls Watch, not agency text
- Talk to your pharmacist or doctor before you stop taking a medicine. FDA: Medication Guides and your medicines (opens in a new tab)
- In an emergency call 911. For a possible poisoning call Poison Help at 1-800-222-1222. Poison Help (HRSA) (opens in a new tab)
- For refunds, repairs or replacements, follow the agency notice. Recalls.gov (opens in a new tab)
Why it was recalled
CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.
FDA classification: Class II. What the FDA’s classes mean (opens in a new tab)
The recalled product
Codes in the record. Click one to copy it.
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000 Capsules per bottle, Rx Only, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain. Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. NDC: 82009-030-10
- Lot or code
- Lot 240927C, Exp 04/30/2027
- FDA recall number
- D-0621-2025
- Quantity
- 3,591 bottles
Distribution (FDA): AZ, IN, NJ
Source
- Issued by
- U.S. Food and Drug Administration
- Firm
- Breckenridge Pharmaceutical, Inc.
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.